Severe Dizziness and Syncope After HeartMate 3 Implantation Requiring Pump Exchange

Ann Thorac Surg. 2019 Sep;108(3):e149-e151. doi: 10.1016/j.athoracsur.2019.01.067. Epub 2019 Mar 7.

Abstract

Implantation of the HeartMate 3 (HM3) left ventricular assist device (Abbott Laboratories, Lake Bluff, IL) continues to increase as the results of European and U.S. clinical trials become available. Although the large trials adequately capture the more common and expected outcomes, rare and unexpected clinical complications will continue to appear with higher volumes of implantation. This report describes a rare complication of severe refractory postural dizziness and syncope after successful implantation of an HM3 in a patient who ultimately required pump exchange to a HeartWare HVAD (HeartWare, Framingham, MA) for resolution of symptoms.

Publication types

  • Case Reports

MeSH terms

  • Cardiac Output, Low / diagnosis
  • Cardiomyopathy, Dilated / complications*
  • Cardiomyopathy, Dilated / diagnostic imaging
  • Computed Tomography Angiography*
  • Device Removal
  • Dizziness / diagnosis
  • Dizziness / etiology
  • Echocardiography / methods
  • Equipment Failure
  • Follow-Up Studies
  • Heart-Assist Devices / adverse effects*
  • Humans
  • Imaging, Three-Dimensional
  • Male
  • Middle Aged
  • Postoperative Complications / diagnostic imaging
  • Postoperative Complications / surgery
  • Prosthesis Implantation / adverse effects
  • Prosthesis Implantation / methods
  • Reoperation / methods*
  • Severity of Illness Index
  • Syncope / diagnosis
  • Syncope / etiology
  • Treatment Outcome
  • Ventricular Dysfunction, Left / diagnostic imaging
  • Ventricular Dysfunction, Left / etiology
  • Ventricular Dysfunction, Left / surgery*